SLC29A1 Anticorps
(Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1))
Choisissez l’un des 91 anticorps SLC29A1 de notre liste de produits basés sur 7 publications et 35 images de validation.
Découvrez des anticorps SLC29A1 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de SLC29A1 dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Monkey, Bat, Dog, Horse, Rabbit, Arabidopsis thaliana, Goat, Guinea Pig, Hamster, et prend en charge diverses applications de recherche telles que WB, ELISA, IHC, IF (cc), IF (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants SLC29A1, issus de différents hôtes tels que Rabbit, Mouse, Goat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de SLC29A1 sont SLC29A1, Slc29a1.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| SLC29A1 anticorps (AA 201-300) (Cy7) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (FITC) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (Cy3) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (Cy5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (HRP) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (Biotin) | Humain | Lapin Polyclonal |
|
419,50 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 201-300) (Cy5.5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| SLC29A1 anticorps (pSer254) | Humain | Lapin Polyclonal |
|
821,15 €
Voir le prix
|
|
| SLC29A1 anticorps (3rd Intracellular Loop) | Humain, Souris | Lapin Polyclonal |
|
1.466,46 €
Voir le prix
|
|
| SLC29A1 anticorps (N-Term) | Humain, Souris, Rat, Singe, Boeuf (Vache), Chien | Lapin Polyclonal |
|
330,77 €
Voir le prix
|
|
| SLC29A1 anticorps (C-Term) | Humain | Lapin Polyclonal |
|
821,15 €
Voir le prix
|
|
| SLC29A1 anticorps (C-Term) | Humain | Lapin Polyclonal |
|
948,75 €
Voir le prix
|
|
| SLC29A1 anticorps (C-Term) (FITC) | Humain | Lapin Polyclonal |
|
1.193,54 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 1-456) | Humain | Souris Polyclonal |
|
933,96 €
Voir le prix
|
|
| SLC29A1 anticorps | Humain | Lapin |
|
717,31 €
Voir le prix
|
|
| SLC29A1 anticorps | Humain | Souris Monoclonal |
|
416,90 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 228-291) (FITC) | Humain | Lapin Polyclonal |
|
628,83 €
Voir le prix
|
|
| SLC29A1 anticorps (AA 228-291) | Humain, Souris | Lapin Polyclonal |
|
628,83 €
Voir le prix
|
|
| SLC29A1 anticorps (Alexa Fluor 555) | Humain | Lapin Polyclonal |
|
543,40 €
Voir le prix
|
|
| SLC29A1 anticorps (Alexa Fluor 680) | Humain | Lapin Polyclonal |
|
543,40 €
Voir le prix
|
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy7
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- HRP
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Biotin
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5.5
- Isotype
- IgG
- Epitope
- AA 201-300
Primary Antibody
- EIA (Enzyme Immunoassay: Application indiquée)
1 reference - Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- Ig Fraction
- Epitope
- pSer254
Primary Antibody
- M (Molecule: Image de validation disponible)
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- 3rd Intracellular Loop, AA 245-260
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- Reactivité
- Humain, Souris, Rat, Singe, Boeuf (Vache), Chien
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- EIA (Enzyme Immunoassay: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- Ig Fraction
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 402-431, C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 402-431, C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 1-456
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Conjugué
- unconjugated
Primary Antibody
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- ABS0168
- Conjugué
- unconjugated
- Isotype
- IgG2a, kappa
Primary Antibody
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 228-291
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF/ICC (Immunofluorescence (fixed cells): Application indiquée)
- Reactivité
- Humain, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 228-291
Primary Antibody
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Alexa Fluor 555
Primary Antibody
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Alexa Fluor 680
Dernières publications pour nos SLC29A1 Anticorps
: "Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine." dans: Nature, (2022) (PubMed).
: "In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer ..." dans: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, (2017) (PubMed).
: "Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5." dans: Oncotarget, Vol. 8, Issue 7, pp. 11748-11762, (2017) (PubMed).
: "Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated ..." dans: British journal of cancer, Vol. 111, Issue 7, pp. 1275-84, (2014) (PubMed).
: "Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in ..." dans: Surgery, Vol. 153, Issue 4, pp. 565-75, (2013) (PubMed).
: "Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine ..." dans: Annals of surgical oncology, Vol. 19 Suppl 3, pp. S646-55, (2012) (PubMed).
: "Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. ..." dans: The Journal of clinical investigation, Vol. 122, Issue 2, pp. 693-710, (2012) (PubMed).
: "Host-based ribavirin resistance influences hepatitis C virus replication and treatment response." dans: Journal of virology, Vol. 85, Issue 14, pp. 7273-83, (2011) (PubMed).
: "Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1." dans: Anticancer research, Vol. 31, Issue 10, pp. 3171-80, (2011) (PubMed).
: "Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance." dans: Journal of virology, Vol. 83, Issue 9, pp. 4538-47, (2009) (PubMed).
: "In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer ..." dans: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, (2017) (PubMed).
: "Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5." dans: Oncotarget, Vol. 8, Issue 7, pp. 11748-11762, (2017) (PubMed).
: "Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated ..." dans: British journal of cancer, Vol. 111, Issue 7, pp. 1275-84, (2014) (PubMed).
: "Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in ..." dans: Surgery, Vol. 153, Issue 4, pp. 565-75, (2013) (PubMed).
: "Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine ..." dans: Annals of surgical oncology, Vol. 19 Suppl 3, pp. S646-55, (2012) (PubMed).
: "Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. ..." dans: The Journal of clinical investigation, Vol. 122, Issue 2, pp. 693-710, (2012) (PubMed).
: "Host-based ribavirin resistance influences hepatitis C virus replication and treatment response." dans: Journal of virology, Vol. 85, Issue 14, pp. 7273-83, (2011) (PubMed).
: "Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1." dans: Anticancer research, Vol. 31, Issue 10, pp. 3171-80, (2011) (PubMed).
: "Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance." dans: Journal of virology, Vol. 83, Issue 9, pp. 4538-47, (2009) (PubMed).
Pseudonymes pour SLC29A1 Anticorps
solute carrier family 29 member 1 (Augustine blood group) (SLC29A1) Anticorpssolute carrier family 29 member 1 (Slc29a1) Anticorps
solute carrier family 29 (nucleoside transporters), member 1 (Slc29a1) Anticorps
1200014D21Rik Anticorps
AA407560 Anticorps
ENT1 Anticorps
rENT1 Anticorps
Avez-vous cherché autre chose?
- SLC28A3 Anticorps
- SLC28A2 Anticorps
- SLC28A1 Anticorps
- SLC27A6 Anticorps
- SLC27A5 Anticorps
- SLC27A4 Anticorps
- SLC27A3 Anticorps
- SLC27A2 Anticorps
- Slc26a9 Anticorps
- SLC26A8 Anticorps
- SLC26A7 Anticorps
- SLC26A6 Anticorps
- SLC26A5 Anticorps
- SLC26A4 Anticorps
- SLC26A3 Anticorps
- SLC26A2 Anticorps
- SLC26A11 Anticorps
- SLC26A10 Anticorps
- SLC26A1 Anticorps
- SLC25A6 Anticorps
- SLC29A2 Anticorps
- SLC29A3 Anticorps
- SLC29A4 Anticorps
- SLC2A10 Anticorps
- SLC2A11 Anticorps
- SLC2A13 Anticorps
- SLC2A14 Anticorps
- SLC2A2 Anticorps
- SLC2A3 Anticorps
- SLC2A4RG Anticorps
- SLC2A5 Anticorps
- SLC2A6 Anticorps
- SLC2A7 Anticorps
- SLC2A8 Anticorps
- SLC2A9 Anticorps
- SLC30A10 Anticorps
- Slc30a3 Anticorps
- SLC30A4 Anticorps
- SLC30A5 Anticorps
- SLC30A6 Anticorps
Vous êtes ici:
